Article feature image

Fate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q3 2021 Results – Earnings Call Transcript

Stock Analysis

Fate Therapeutics, Inc. (NASDAQ:FATE) Q3 2021 Earnings Conference Call November 4, 2021 5:00 PM ET
Company Participants
Scott Wolchko – President and CEO
Ed Dulac – CFO
Wayne Chu – SVP, Clinical development
Conference Call Participants
Michael Yee – Jefferies
…

Click here to view the original article.

Tags:
,
Facebook Google+ Twitter Pinterest

Related Posts